US Patent 9260502 Protease-stabilized insulin analogues
Patent 9260502 was granted and assigned to Novo Nordisk on February, 2016 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 13, 2009
Date of Patent
February 16, 2016
Patent Application Number
12922106
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9260502 Protease-stabilized insulin analogues
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.